AmberHealth vs Queen RX
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
AmberHealth
Best for budget-conscious shoppersStarting at $100/mo
Queen RX
Best for budget-conscious patients seeking low-cost compounded GLP-1Starting at $100/mo
Side-by-Side Comparison
| Feature | AmberHealth | Queen RX |
|---|---|---|
| Overall Score | ✓7.7/10 | 7.2/10 |
| Starting Price | $100/mo | $100/mo |
| Editorial Rating | ✓3.9 ★ /5 | 3.6 ★ /5 |
| Features | 3 features | 3 features |
| States Available | ✓50 | 45 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
AmberHealth
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Queen RX
Pros
- ✓$299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
- ✓Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
- ✓45-state coverage
Cons
- ✗No LegitScript or PCAB accreditation
- ✗No legal entity name or address disclosed
- ✗No named pharmacy partners
- ✗Not available in KS, LA, MS, NM, WV
Our Verdict
AmberHealth edges out Queen RX with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Queen RX remains a solid alternative, especially if you're looking for budget-conscious patients seeking low-cost compounded GLP-1.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.